Yissum Research Development, the technology transfer arm of the Hebrew University of Jerusalem, announced that it has participated in a U.S. $3M financing round of Avraham Pharmaceuticals, together with Pontifax, Clal Biotechnology, Technion Research and Development Foundation, Professor Marta Weinstock-Rosin and others.
Read More